Faculty Anna Carlo Roberto Federico Yihai Loredana Louis Stefania Tatiana Ruggero Cosmo Damiano Enzo Giampietro Raffaella Pedro Miguel Paolo Antonio Mauro Alessandro Stefania Giorgio Camillo Carmelo Roberta Andrea Masakazu Giampaolo MEETING VENUE NH Hotel Vittorio Veneto Corso Italia, 1 - 00198 Roma Ph. +39 06.84951 Bagnato Barone Bordonaro Bussolino Cao Casalis Chow D’Atri Da Ros De Maria Gadaleta Galligioni Gasparini Giavazzi Lacal Marchetti Marchetti Minelli Morabito Nobili Parmiani Porta Pozzo Sarmiento Sartore Bianchi Toi Tortora Roma Roma Catania Candiolo (TO) Stockholm, Sweden Trieste Hong Kong, China Roma Trieste Roma Bari Trento Roma Milano Roma Roma Chieti Roma Napoli Firenze Milano Pavia Roma Roma Milano Kyoto, Japan Verona ITALIAN CME (Continuing Medical Education) The Italian Ministry of Health allows no. 10 CME credits for Biologists, Chemists and Physicians specialized in Oncology and Anatomopathology. - Provider Studio ER Congressi SRL - ID 828-111755 - Educational objective: guide lines - protocols - procedures 210174 .ercongressi.it VII INTERNATIONAL CONFERENCE IN MEMORY OF JUDAH FOLKMAN TRANSLATIONAL STUDIES ON ANGIOGENESIS AND TARGETED THERAPY IN ONCOLOGY Rome, January 23-24, 2015 NH Hotel Vittorio Veneto President: Giampietro Gasparini Co-Chairs: Federico Bussolino, Yihai Cao SCIENTIFIC SECRETARIAT Daniela Mazzocco S.C. Oncologia A.C.O. San Filippo Neri, Roma Ph. +39 06.33062237 ORGANIZING SECRETARIAT Studio E.R. Congressi - Triumph Group Via Marconi, 36 - 40122 Bologna Ph. +39 051.4210559 - Fax +39 051.4210174 E-mail: [email protected] www.ercongressi.it Auspices AIOM Associazione Italiana di Oncologia Medica OOTR Organization for Oncology and Translational Research A.C.O. San Filippo Neri SIC Società Italiana di Cancerologia AITBI Associazione Italiana per le Terapie Biologiche Innovative Associazione Culturale “G. Dossetti” Ordine Provinciale dei Medici e Chirurghi di Roma SIMG Società Italiana di Medicina Generale Regione Lazio Comune di Roma January 24, 2015 January 23, 2015 9.30 a.m. Introduction G. Gasparini SESSION I: STUDIES ON ANGIOGENESIS Chairmen: R. De Maria, R. Giavazzi 9.45 -10.15 a.m. LECTURE: Novel topics from basic research F. Bussolino 10.15 - 10.35 a.m. Experimental antiangiogenic therapy in ovarian cancer R. Giavazzi 10.35 - 10.55 a.m. Expression of the VEGF-A co-receptor neuropilin in melanoma: role in tumor aggressiveness P.M. Lacal 10.55 - 11.15 a.m. Innovative therapeutic strategy targeting tumor and endothelial cells: the endothelin axis A. Bagnato 11.15 - 11.30 a.m. General Discussion SESSION II: ANTI-HER2 and ANTI-EGFR THERAPY Chairmen: A. Marchetti, G. Tortora 11.30 - 12.00 p.m. LECTURE: Understanding the pathways for the optimal therapeutic strategy in colorectal cancer G. Tortora 12.00 - 12.20 p.m. Clinical relevance of the new anti-HER2 agents R. Sarmiento 12.20 - 12.40 p.m. Anti-EGFR therapy of lung cancer A. Morabito 1.15 - 2.30 p.m. Lunch SESSION III: APPLICATION OF NANOTECHNOLOGIES IN ONCOLOGY Chairmen: T. Da Ros, G. Gasparini 2.30 - 3.00 p.m. LECTURE: Laboratory research for development of nanotechnologies T. Da Ros 3.00 - 3.20 p.m. Sensitive methods for HER2 protein determination L. Casalis 3.20 - 3.40 p.m. Anticancer nanotech agents S. Nobili 3.40 - 4.00 p.m. General Discussion SESSION IV: ADVANCES IN IMMUNOTHERAPY OF CANCER Chairmen: S. D’Atri, E. Galligioni 4.00 - 4.30 p.m. LECTURE: The new era of immunotherapy of cancer G. Parmiani 4.30 - 4.50 p.m. Advances of therapy of malignant melanoma E. Galligioni 4.50 - 5.10 p.m. General Discussion 9.00 - 9.30 a.m. SPECIAL LECTURE: OOTR traslational studies in breast cancer L. Chow SESSION V: ANTIANGIOGENIC THERAPY Chairmen: Y. Cao, M. Toi 9.30 – 10.00 a.m. LECTURE: Clinically relevant angiogenic pathways Y. Cao 10.00 – 10.20 a.m. Antiangiogenic therapy of breast cancer M. Toi 10.20 – 10.40 a.m. Advances for therapy of triple negative breast cancer P. Marchetti 10.40 – 11.00 a.m. Antiangiogenic therapy of gastric cancer C. Pozzo 11.00 - 11.20 a.m. Antiangiogenic therapy of renal cancer C. Porta 11.20 - 11.40 a.m. General Discussion SESSION VI: GASTROINTESTINAL CANCERS Chairmen: M. Minelli, A. Sartore Bianchi 11.40 - 12.10 p.m. LECTURE: Clinical approach to targeting drug resistance in colorectal cancer A. Sartore Bianchi 12.10 - 12.30 p.m. Optimal sequencing treatments C. Barone 12.40 - 1.00 p.m. Anti-EGFR therapy of colorectal cancer R. Bordonaro 12.30 -12.50 p.m. Role of loco-regional therapeutic approaches for organ-confined metastasis C.D. Gadaleta 1.00 - 1.15 p.m. General Discussion 12.50 - 13.10 p.m. General Discussion Judah Folkman